THE DEAL, AT A GLANCE
2/4 explanations supportedMithrl
Mithrl
Mithrl helps drug researchers find biologically grounded drug target candidates from experimental data.
01What it doesMithrl helps drug researchers find biologically grounded drug target candidates from experimental data.Source-grounded · automated review · Explore ↗
Checked 2026-09-15 · Review due 2026-09-22
Read supporting source ↗Discover novel drug target candidates…
02Who is involvedEvidence still neededOpen review status ↗
The draft correctly does not name investors. Document 0 contains no Series A investor names, prior-round investors, arranger roles, lender roles, or financing participants.
03What happenedEvidence still neededOpen review status ↗
The draft correctly says the supplied source does not establish a Series A amount, currency, date, or announcement status. Document 0 contains no financing event details.
04Why it mattersIt supports early drug discovery by combining lab data with organized biological knowledge.Interpretation · Explore ↗
Checked 2026-09-15 · Review due 2026-09-22
Read supporting source ↗combining your experimental data with…
Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
Mithrl · Financing Record
Explore source-linked visual explanations for Mithrl. Unsupported claims are withheld while source review continues.
Record 12348 · Recorded date: 2026-09-15
Explore company records →